Literature DB >> 22115934

Impaired β-adrenergic receptor signalling in post-resuscitation myocardial dysfunction.

Xian-Fei Ji1, Lin Yang, Chun-Sheng Li.   

Abstract

OBJECTIVE: Post-resuscitation myocardial dysfunction is a major cause of fatality in patients receiving successful cardiopulmonary resuscitation. The mechanism of post-resuscitation myocardial dysfunction is largely unknown, although is generally considered related to ischaemia occurring during cardiac arrest and resuscitation and/or reperfusion injury after restoration of circulation. A key mechanism responsible for reduced contractile reserves in chronic heart failure is impaired β-adrenergic receptor signalling. Thus, we hypothesised that β-adrenergic receptor signalling is markedly abnormal in the post-resuscitation period following cardiopulmonary resuscitation.
METHODS: Male landrace domestic pigs were randomised into a sham group (anaesthetised and instrumented, no ventricular fibrillation) or cardiopulmonary resuscitation (CPR) group (ventricular fibrillation) (n=8 per group). Haemodynamic and echocardiographic data were recorded. β-Adrenergic receptor signalling was assessed at 6h after the operation by measuring myocardial adenylate cyclase activity, β-adrenergic receptor density and β-adrenergic receptor kinase expression.
RESULTS: Left ventricular function in the CPR group was significantly decreased at 6 h after restoration of spontaneous circulation. Basal and isoproterenol-stimulated adenylate cyclase activity was blunted in the CPR group compared with the sham group. Total β-AR density was significantly decreased in CPR group compared with the sham group. Myocardial β-adrenergic receptor kinase expression was 2.03-fold greater in the CPR group than in the sham group.
CONCLUSIONS: β-Adrenergic receptor signalling is markedly impaired in the post-resuscitation period, which may be a mechanism of post-resuscitation myocardial dysfunction.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22115934     DOI: 10.1016/j.resuscitation.2011.11.014

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  7 in total

Review 1.  Therapeutic effects of Shenfu Injection on post-cardiac arrest syndrome.

Authors:  Zhi-jun Guo; Chun-sheng Li
Journal:  Chin J Integr Med       Date:  2013-08-24       Impact factor: 1.978

Review 2.  Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.

Authors:  Bernardo Sousa-Pinto; Manuel J Ferreira-Pinto; Mário Santos; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

3.  The Association of Extreme Tachycardia and Sustained Return of Spontaneous Circulation after Nontraumatic Out-of-Hospital Cardiac Arrest.

Authors:  Dong Keon Lee; Eugi Jung; You Hwan Jo; Joonghee Kim; Jae Hyuk Lee; Seung Min Park; Yu Jin Kim
Journal:  Emerg Med Int       Date:  2020-06-29       Impact factor: 1.112

4.  Shen-Fu Injection () alleviates post-resuscitation myocardial dysfunction by up-regulating expression of sarcoplasmic reticulum Ca(2+)-ATPase.

Authors:  Zhi-Jun Guo; Cai-Jun Wu; Chun-Sheng Li
Journal:  Chin J Integr Med       Date:  2015-08-11       Impact factor: 1.978

5.  Effect of mild hypothermia on the coagulation-fibrinolysis system and physiological anticoagulants after cardiopulmonary resuscitation in a porcine model.

Authors:  Ping Gong; Ming-Yue Zhang; Hong Zhao; Zi-Ren Tang; Rong Hua; Xue Mei; Juan Cui; Chun-Sheng Li
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

Review 6.  Myocardial Dysfunction and Shock after Cardiac Arrest.

Authors:  Jacob C Jentzer; Meshe D Chonde; Cameron Dezfulian
Journal:  Biomed Res Int       Date:  2015-09-02       Impact factor: 3.411

7.  Associations between red cell distribution width and outcomes of adults with in-hospital cardiac arrest: A retrospective study.

Authors:  Yanwei Cheng; Hailin Peng; Jiange Zhang; Juan Zhu; Lijun Xu; Xue Cao; Lijie Qin
Journal:  Medicine (Baltimore)       Date:  2022-01-28       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.